Early Real-World Experience with CoreValve Evolut PRO and R Systems for Transcatheter Aortic Valve Replacement
Table 4
Discharge and 30-day echocardiogram findings.
Evolut PRO
Evolut R
value
PVL—discharge
Trace/none
40/60 (66.6)
36/56 (64.3)
0.65
Mild
17/60 (28.3)
14/56 (25)
0.68
Moderate
3/60 (5)
6/56 (10.7)
0.25
Severe
0/60
0/56
—
Aortic valve function—discharge
EF
67.9 ± 10.3
65.8 ± 9.4
0.19
Mean transaortic valve gradient (mm Hg)
8.5 ± 4.6
8.2 ± 4.0
0.99
Maximum aortic velocity (m/s)
1.9 ± 0.4
1.9 ± 0.4
0.78
Aortic valve area (cm2)
1.9 ± 0.4
1.9 ± 0.5
0.45
Aortic valve area index (cm2/m2)
1.4 ± 0.7
1.1 ± 0.3
0.007
PVL—30 days
Trace/none
27/53 (50.9)
25/46 (58.7)
0.73
Mild
20/53 (37.7)
14/46 (30.4)
0.45
Moderate
6/53 (11.3)
6/46 (13.0)
0.79
Severe
0/53
0/46
—
Aortic valve function—30 days
EF
62.2 ± 11.3
66.6 ± 9.3
0.62
Mean transaortic valve gradient (mm Hg)
7.0 ± 3.3
8.1 ± 4.3
0.19
Maximum aortic velocity (m/s)
1.8 ± 0.4
1.8 ± 0.5
0.69
Values are mean ± standard deviation, n/N (%). Note that 30-day echocardiogram findings were not available for the entire population. Aortic valve area and aortic valve area index not available at 30 days.
